Dr Nikolaos Diamantis, Consultant Medical Oncologist, Gastrointestinal Cancers & Neuroendocrine Tumours
Dr Nikolaos Diamantis
Consultant Medical Oncologist, Gastrointestinal Cancers & Neuroendocrine Tumours
Dr Nikolaos Diamantis MD MRCP PhD
Consultant Medical Oncologist, Gastrointestinal Cancers & Neuroendocrine Tumours
Dr Nikolaos Diamantis
Consultant Medical Oncologist, Gastrointestinal Cancers & Neuroendocrine Tumours MD MRCP PhD
Dr Diamantis is a Consultant Medical Oncologist, Gastrointestinal Cancers & Neuroendocrine Tumours
Areas of expertise
- Bile duct cancer (cholangiocarcinoma)
- Bowel cancer
- Colorectal cancer
- Gastrointestinal cancers
- Medical oncology
Make an appointment
Address
-
LOC at Platinum Medical Centre
15-17 Lodge Road, St Johns Wood, London, NW8 7JA
About Dr Nikolaos Diamantis
GMC number: 7013255
Year qualified: 2004
Place of primary qualification: National Capodistrian University of Athens
Dr Nikos Diamantis is a Medical Oncology Consultant at St Bartholomew's Hospital, specialising in colorectal, oesophageal, gastric, pancreatic, liver, and bile duct cancers, as well as cancers of unknown primary. He has been with the hospital since 2015 and serves as the Barts Trust Lead for Acute Oncology and Cancer of Unknown Primary.
Dr Diamantis completed his specialist training at Imperial College Healthcare, including Hammersmith, St Mary's, and Harefield Hospitals. He was awarded the Greek national Oncology fellowship scholarship and conducted clinical research for two years at the Drug Development Unit of the Royal Marsden.
His research interests focus on immunotherapy for gastrointestinal malignancies and first-in-human clinical trials. Dr Diamantis is a Principal Investigator for several Phase 2 and 3 trials, contributing significantly to advancements in oncology treatments.
In addition to his clinical and research roles, Dr Diamantis is deeply committed to patient care and education. He holds an MD, MRCP, and PhD, and has earned numerous certifications, including the ESMO Medical Oncology Certificate. His dedication to oncology is evident in his ongoing efforts to improve treatment outcomes and patient experiences.
Areas of expertise
- Adenocarcinoma
- Barrett's oesophagus
- Bile duct cancer (cholangiocarcinoma)
- Biliary cancer
- Bowel cancer
- Cancer of unknown primary
- Cancer prevention and screening
- Carcinoma of unknown primary
- Chemotherapy
- Clinical trials
- Colon cancer
- Colorectal cancer
- Gallbladder cancer
- Gastrointestinal cancers
- Gastro-intestinal malignancies
- Immunotherapy
- Liver cancer
- Medical oncology
- Neoadjuvant
- Neuroendocrine tumours
- Oesophageal cancer
- Oligometastic disease
- Pancreatic cancer
- Rare cancer
- Rectal cancer
- Small bowel cancer
- Stomach (gastric) cancer
- Targeted therapy
Professional memberships
Articles by Dr Nikolaos Diamantis
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer
Time-dependent covid-19 mortality in patients with cancer
Covid-19 sequelae and the host proinflammatory response
Persistence of long-term COVID-19 sequelae in patients with cancer
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection
COVID-19 in breast cancer patients
